(Q45291180)

11 December 2017

title

Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans (English)

1 reference

11 December 2017

H Toyama

1

1 reference

11 December 2017

M Ichise

2

1 reference

11 December 2017

J R Ballinger

3

1 reference

11 December 2017

L Fornazzari

4

1 reference

11 December 2017

J C Kirsh

5

1 reference

11 December 2017

publication date

1 February 1993

1 reference

Annals of Nuclear Medicine

11 December 2017

published in

1 reference

11 December 2017

volume

7

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

29-38

1 reference

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

11 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03164789

Imaging of neurotransmitter receptors in the living human brain

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03164789

Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03164789

A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent

21 January 2018

1 reference

12 December 2020

Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

1 reference

12 December 2020

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

12 December 2020

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

1 reference

12 December 2020

Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy.

1 reference

12 December 2020

SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease

1 reference

12 December 2020

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

12 December 2020

Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with123I-IBZM using the rotating gamma camera

1 reference

12 December 2020

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

1 reference

12 December 2020

1 reference

12 December 2020

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

12 December 2020

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

12 December 2020

Dopamine receptor alterations with aging in mouse and rat corpus striatum

1 reference

12 December 2020

Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.

1 reference

12 December 2020

Effect of age on adrenergic and dopaminergic receptor binding in rat brain

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

1 reference

12 December 2020

Multiple D2 dopamine receptors produced by alternative RNA splicing

1 reference

12 December 2020

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy

1 reference

12 December 2020

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

12 December 2020

Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain

1 reference

12 December 2020

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

1 reference

12 December 2020

Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone.

1 reference

12 December 2020

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

12 December 2020

Advances in emission tomography: quo vadis?

1 reference

12 December 2020

Pharmacological implications for neuroreceptor imaging

1 reference

12 December 2020

In vivo characterisation of 3-iodo-6-methoxybenzamide 123I in humans.

1 reference

12 December 2020

The dopamine D2 receptor: two molecular forms generated by alternative splicing

1 reference

12 December 2020

Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging

1 reference

12 December 2020

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent

1 reference

12 December 2020

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

1 reference

12 December 2020

Clinical importance of D-1 and D-2 receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03164789

1 reference

Dimensions Publication ID

11 December 2017

1027801091

0 references

1 reference